ATE308341T1 - Pharmazeutische formulierungen - Google Patents

Pharmazeutische formulierungen

Info

Publication number
ATE308341T1
ATE308341T1 AT01971777T AT01971777T ATE308341T1 AT E308341 T1 ATE308341 T1 AT E308341T1 AT 01971777 T AT01971777 T AT 01971777T AT 01971777 T AT01971777 T AT 01971777T AT E308341 T1 ATE308341 T1 AT E308341T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
nail
onychomycosis
preparation
laser beam
Prior art date
Application number
AT01971777T
Other languages
English (en)
Inventor
Alfredo Emilio Bruno-Raimondi
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE308341T1 publication Critical patent/ATE308341T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Laser Surgery Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01971777T 2000-08-04 2001-07-24 Pharmazeutische formulierungen ATE308341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019283.1A GB0019283D0 (en) 2000-08-04 2000-08-04 Organic compounds
PCT/EP2001/008558 WO2002011764A2 (en) 2000-08-04 2001-07-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE308341T1 true ATE308341T1 (de) 2005-11-15

Family

ID=9897070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01971777T ATE308341T1 (de) 2000-08-04 2001-07-24 Pharmazeutische formulierungen

Country Status (10)

Country Link
US (4) US20030181847A1 (de)
EP (1) EP1307227B1 (de)
JP (3) JP2004505928A (de)
AT (1) ATE308341T1 (de)
AU (1) AU2001291678A1 (de)
DE (1) DE60114635T2 (de)
DK (1) DK1307227T3 (de)
ES (1) ES2252294T3 (de)
GB (1) GB0019283D0 (de)
WO (1) WO2002011764A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
US20040126272A1 (en) * 2002-08-28 2004-07-01 Eric Bornstein Near infrared microbial elimination laser system
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
US20050256553A1 (en) * 2004-02-09 2005-11-17 John Strisower Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
EP1627610A1 (de) * 2004-08-21 2006-02-22 TLT Medical Ltd Verabreichung eines Medikaments durch Applikation in Nägel
MX2007006833A (es) * 2004-12-10 2007-10-08 Talima Therapeutics Inc Composiciones y metodos para tratar condiciones de la unidad de una.
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US20070104664A1 (en) * 2005-10-26 2007-05-10 California Institute Of Technology Treatment of toenail fungus
JP5095986B2 (ja) * 2005-11-30 2012-12-12 学校法人慶應義塾 経爪無侵襲血中物質測定装置及び爪甲蒸散装置
AU2006332425A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
AU2007208264A1 (en) * 2006-01-24 2007-08-02 Nomir Medical Technologies, Inc. Optical method and device for modulation of biochemical processes in adipose tissue
EP2119408A1 (de) 2008-05-16 2009-11-18 TLT Medical Ltd Photoablator
WO2010097344A1 (en) 2009-02-26 2010-09-02 Basf Se Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
EP2229980B1 (de) * 2009-03-16 2015-08-12 Nuvolase, Inc. Behandlung mikrobiologischer Krankheitserreger in einem Zehennagel mit antimikrobiellem Licht
US8814922B2 (en) * 2009-07-22 2014-08-26 New Star Lasers, Inc. Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
DE102009038512A1 (de) * 2009-07-30 2011-02-10 Technische Universität Braunschweig Arzneimittelformulierung zur Behandlung von Nagelerkrankungen
JP5699091B2 (ja) * 2009-12-10 2015-04-08 学校法人慶應義塾 爪真菌症治療システム
FR2954164B1 (fr) * 2009-12-18 2012-03-16 Galderma Pharma Sa Composition antifongique destinee a etre appliquee sur l'ongle perfore
US9763735B2 (en) 2011-02-24 2017-09-19 Eximo Medical Ltd. Hybrid catheter for endoluminal intervention
EP2838569A1 (de) * 2012-04-20 2015-02-25 Galderma Research & Development Optimierung einer nagelbehandlung mittels quantitativer autoradiographie
EP2950731A4 (de) * 2013-01-31 2017-01-04 Eximo Medical Ltd. Hybridkathetervorrichtung und verfahren
US12514456B2 (en) 2013-01-31 2026-01-06 Eximo Medical Ltd. System and methods for lesion characterization in blood vessels
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9504849B2 (en) * 2013-03-14 2016-11-29 Plumeria Holdings, Llc Destruction of target cells utilizing harmonic resonance cavitation
US10420608B2 (en) 2014-05-20 2019-09-24 Verily Life Sciences Llc System for laser ablation surgery
US11684420B2 (en) 2016-05-05 2023-06-27 Eximo Medical Ltd. Apparatus and methods for resecting and/or ablating an undesired tissue
EP3603650A1 (de) 2018-08-01 2020-02-05 Edix O Sarl Injizierbare zusammensetzungen mit langzeitwirkung zur verwendung in der behandlung von nagelkrankheiten und/oder zur beschleunigung des nagelwachstums
WO2020025683A1 (fr) 2018-08-01 2020-02-06 Edix-O Sarl Compositions injectables a duree d'action prolongee pour leur utilisation dans le traitement de maladie de l'ongle et/ou pour accelerer la croissance de l'ongle
EP3937816B1 (de) * 2019-03-15 2025-05-21 The General Hospital Corporation Systeme zur lasergestützten topischen behandlung von nagelpilzinfektionen
US11130003B2 (en) * 2019-03-15 2021-09-28 The General Hospital Corporation Systems and methods for laser-assisted topical treatment of nail fungal infections
US11224378B2 (en) * 2019-03-15 2022-01-18 Blossom Innovations, LLC Therapeutic laser system and method
US12376904B1 (en) 2020-09-08 2025-08-05 Angiodynamics, Inc. Dynamic laser stabilization and calibration system
US12038322B2 (en) 2022-06-21 2024-07-16 Eximo Medical Ltd. Devices and methods for testing ablation systems

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180058A (en) * 1978-08-15 1979-12-25 Jacob Brem Method of treating pathological conditions of the nail
JPS5821387A (ja) * 1981-07-29 1983-02-08 Olympus Optical Co Ltd レ−ザ照射装置
US4525842A (en) * 1984-02-24 1985-06-25 Myers John D Laser device and method
US4826513A (en) * 1987-01-12 1989-05-02 Stackhouse Wyman H Laser smoke particulate/odor filter system
US4767333A (en) * 1987-08-17 1988-08-30 Born Grant R Laser evolved models
EP0368512A3 (de) * 1988-11-10 1990-08-08 Premier Laser Systems, Inc. Medizinischer Laser mit variabler Wellenlänge
US5168454A (en) * 1989-10-30 1992-12-01 International Business Machines Corporation Formation of high quality patterns for substrates and apparatus therefor
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5643252A (en) * 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
US6716210B2 (en) * 1992-12-03 2004-04-06 Lasersight Technologies, Inc. Refractive surgical laser apparatus and method
US6251100B1 (en) * 1993-09-24 2001-06-26 Transmedica International, Inc. Laser assisted topical anesthetic permeation
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5554153A (en) * 1994-08-29 1996-09-10 Cell Robotics, Inc. Laser skin perforator
WO1997009960A1 (en) * 1995-09-14 1997-03-20 Sorenson Pharmaceutical, Inc. Composition and method for treating diseased nails
US5782249A (en) * 1996-09-30 1998-07-21 Weber; Paul J. Laser manicure process
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
JP2001510773A (ja) * 1997-07-28 2001-08-07 ダーマトレイザー テクノロジーズ リミテッド 光線療法に基づく病原体の治療方法及びそれを達成するための組成物
US5947956A (en) * 1997-11-04 1999-09-07 Karell; Manuel Leon Laser apparatus for making holes and etchings
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same
US6286517B1 (en) * 1998-12-22 2001-09-11 Pearl Technology Holdings, Llc Fingernail and toenail decoration using ink jets
US6449294B1 (en) * 1999-07-26 2002-09-10 Pls Liquidating Llc Single dominant spike output erbium laser
US6403063B1 (en) * 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
JP2001235850A (ja) * 2000-02-24 2001-08-31 Sony Corp フォトマスクパターンの設計方法、レジストパターンの形成方法および半導体装置の製造方法
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
US6706032B2 (en) * 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
US20080183162A1 (en) * 2000-12-28 2008-07-31 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
AU2002316500A1 (en) * 2001-07-02 2003-01-21 Palomar Medical Technologies, Inc. Laser device for medical/cosmetic procedures
WO2005065565A1 (en) * 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US20050256552A1 (en) * 2004-05-17 2005-11-17 White Robert L Toenail fungus eradicator

Also Published As

Publication number Publication date
GB0019283D0 (en) 2000-09-27
US20070004756A1 (en) 2007-01-04
AU2001291678A1 (en) 2002-02-18
ES2252294T3 (es) 2006-05-16
JP2008132349A (ja) 2008-06-12
DE60114635T2 (de) 2006-07-20
WO2002011764A2 (en) 2002-02-14
EP1307227B1 (de) 2005-11-02
JP2004505928A (ja) 2004-02-26
US20030181847A1 (en) 2003-09-25
US20100113607A1 (en) 2010-05-06
DK1307227T3 (da) 2006-03-06
US20110082448A1 (en) 2011-04-07
WO2002011764A3 (en) 2002-04-25
DE60114635D1 (de) 2005-12-08
EP1307227A2 (de) 2003-05-07
JP2011132247A (ja) 2011-07-07

Similar Documents

Publication Publication Date Title
DE60114635D1 (de) Pharmazeutische formulierungen
AR032293A1 (es) Estuche farmaceutico
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
MXPA05012573A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de cinasa.
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
CY1116055T1 (el) Σκευασματα υδροξυματαιρεσινολης για τοπικη εφαρμογη
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
CY1106774T1 (el) Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
UY27186A1 (es) Formulación farmacéutica
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
HN2003000185A (es) Difenilazetidinonas sustituidas en grupo acido, procedimiemto para su preparacion, medicamentos que comprenden estso compuestos y su uso.
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad
ECSP044985A (es) Azitromicina de dosis única para infecciones respiratorias
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
ITRM20020562A1 (it) Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
ES2146423T3 (es) Procedimiento para la preparacion de disulfuros y polisulfuros organicos en presencia de resinas de poliestireno-divinilbenceno (ps-dvb) que tienen grupos de guanidina o de amidina.
ECSP003551A (es) Complejo farmaceutico
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1307227

Country of ref document: EP